[Real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China]
【中国帕立普韦/利托那韦-奥比他韦联合达沙布韦治疗慢性丙型肝炎1b基因型感染的真实世界研究】
期刊:Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
影响因子:
doi:10.3760/cma.j.issn.1007-3418.2019.02.010
Jie, Y S; Yuan, J; Zhang, X H; Guan, Y J; Zhao, Z X; Chong, Y T; Tao, L; Li, J P; Lin, C S